October 2025 in “Journal of Pharmacy And Bioallied Sciences” PRP significantly improves hair density and satisfaction in hair restoration.
October 2025 in “Journal of Craniofacial Surgery” Chitosan and minoxidil both improve hair growth, but more research is needed on chitosan.
October 2025 in “International Journal of Nutrology” Improving gut health can enhance skin health and aid in treating skin diseases.
September 2025 in “Surgeries” Hair transplants can work for stable cicatricial alopecia, but success varies by condition.
Keratin could help create enamel-regenerating toothpaste in a few years.
Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.
September 2025 in “Journal of Cutaneous Medicine and Surgery” Experts recommend specific treatments like minoxidil and finasteride for managing hereditary hair loss.
September 2025 in “Tạp chí Da liễu học Việt Nam” Combining oral methylprednisolone with microneedle radiofrequency improves hair growth in alopecia areata but may cause pain and side effects.
September 2025 in “Cureus” GLP-1 receptor agonists may cause hair loss, but more research is needed.
September 2025 in “BULLETIN OF STOMATOLOGY AND MAXILLOFACIAL SURGERY” Better supportive care is needed to manage chemotherapy side effects.
September 2025 in “Clinical Cosmetic and Investigational Dermatology” Kūlaris improved quality of life for acne sufferers without side effects.
August 2025 in “Journal of Cosmetic Dermatology” Light-based therapy can help regrow hair in different types of hair loss, but more research is needed.
The model accurately predicts hair loss severity in alopecia areata.
August 2025 in “Journal of Cosmetic Dermatology” The dietary supplement AGA-P improves the effectiveness of hair loss treatments.
August 2025 in “Journal of the American Academy of Dermatology” Combining PRP with microneedling and minoxidil may help treat severe hair loss.
August 2025 in “International Journal of Research in Dermatology” Combining glucocorticoids with immunosuppressants like cyclophosphamide improves remission and reduces relapse in pemphigus patients.
August 2025 in “International Journal of Molecular Sciences” Topical minoxidil 5% is the most effective over-the-counter treatment for male hair loss.
July 2025 in “Skin Health and Disease” PRP is a good alternative or addition to minoxidil for treating hair loss.
June 2025 in “British Journal of Dermatology” Low-dose oral minoxidil is increasingly used by dermatologists in the UK and Ireland to treat various hair loss conditions.
The combination of minoxidil, microneedling, and PRP is more effective for hair growth than minoxidil alone.
June 2025 in “Journal of Population Therapeutics and Clinical Pharmacology” The combination of microneedling, PRP, and minoxidil is more effective for hair loss than minoxidil alone.
June 2025 in “Journal of Cosmetic Dermatology” Botanical extract shampoo and tonic improved hair loss in most participants.
April 2025 in “Skin Appendage Disorders” Vitamin D may help reduce severity and relapse of alopecia areata.
April 2025 in “Journal of Applied Cosmetology” The combined therapy of microneedling and light therapy effectively and safely promotes hair regrowth in trichotillomania.
April 2025 in “Frontiers in Bioengineering and Biotechnology” Gel-SHP helps skin heal faster.
April 2025 in “Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 )” Cuscuta reflexa extract may help treat benign prostatic hyperplasia by reducing inflammation and oxidative stress.
April 2025 in “Skin Health and Disease” Oral minoxidil is an effective alternative for hair loss but may cause more unwanted hair growth.
March 2025 in “Archives of Dermatological Research” Combined microneedling with minoxidil improves hair growth more than minoxidil alone but may cause mild side effects.
March 2025 in “Journal of Bio Innovation” Microsporum canis causes ringworm in dogs and cats, treatable with topical and oral antifungals.
Janus kinase inhibitors are the most supported treatment for pediatric alopecia areata, while other options have limited evidence.